HealthEquity, Inc. $HQY Shares Bought by Waverly Advisors LLC

Waverly Advisors LLC grew its position in HealthEquity, Inc. (NASDAQ:HQY) by 20.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 73,569 shares of the company’s stock after acquiring an additional 12,514 shares during the quarter. Waverly Advisors LLC owned approximately 0.09% of HealthEquity worth $6,645,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Acumen Wealth Advisors LLC acquired a new position in HealthEquity in the fourth quarter worth $27,000. Aster Capital Management DIFC Ltd bought a new position in shares of HealthEquity in the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd boosted its holdings in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after buying an additional 293 shares during the period. Leonteq Securities AG boosted its holdings in shares of HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after buying an additional 235 shares during the period. Finally, Silvant Capital Management LLC bought a new stake in shares of HealthEquity during the 2nd quarter valued at about $35,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Up 2.0%

HealthEquity stock opened at $94.55 on Friday. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $107.62. The stock has a market cap of $7.82 billion, a price-to-earnings ratio of 34.13, a PEG ratio of 1.46 and a beta of 0.22. The company’s 50-day moving average price is $99.58 and its two-hundred day moving average price is $89.18. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. HealthEquity’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, analysts expect that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have issued reports on HQY. Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $135.00 to $142.00 and gave the stock a “buy” rating in a research report on Monday, August 31st. Telsey Advisory Group set a $111.00 price objective on HealthEquity in a research report on Friday, August 28th. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research note on Friday, August 28th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $111.87.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Fiore sold 2,470 shares of the company’s stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total transaction of $234,650.00. Following the completion of the sale, the executive vice president directly owned 56,643 shares of the company’s stock, valued at $5,381,085. This represents a 4.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Adrian T. Dillon sold 7,632 shares of the stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the transaction, the director owned 62,395 shares of the company’s stock, valued at $6,527,140.95. This trade represents a 10.90% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,456 shares of company stock worth $1,256,664 in the last ninety days. 1.60% of the stock is owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services for consumer-directed benefits and healthcare savings accounts. The company helps employers, benefits advisors and individuals manage tax-advantaged accounts, including health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), commuter benefits and other employee benefit programs.

Its offerings include account administration, payment cards, reimbursement services, benefits communication, compliance support, healthcare spending tools and investment options for eligible HSA funds.